Vestibular Rehabilitation for Unsteadiness After Intratympanic Gentamicin in Patients With Meniere's Disease

Launched by EYE & ENT HOSPITAL OF FUDAN UNIVERSITY · Nov 16, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how effective vestibular rehabilitation therapy is for people who feel unsteady after receiving a specific treatment called intratympanic gentamicin for Meniere's disease, which affects balance. The goal is to see if this type of therapy can help improve balance and reduce feelings of unsteadiness in patients.

To participate in this study, you need to be between 18 and 75 years old and have experienced ongoing balance issues for at least a month after your gentamicin treatment. You'll also need to be willing to sign a consent form agreeing to take part in the trial. However, if you have certain conditions like severe neck problems, other inner ear diseases, or significant psychological issues, you won't be eligible to join. This trial is not currently recruiting participants, but it aims to help improve treatment options for those struggling with balance issues related to Meniere's disease.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Adults aged between 18 and 75 years old;
• • 2. Complained of persistent unsteadiness 1 month after intratympanic gentamicin treatment;
• • 3. Be willing to sign the informed consent of the study.
• Exclusion Criteria:
• • 1. Conformed to neuromuscular disease;
• • 2. Conformed to severe cervical spine disease;
• • 3. Conformed to congenital inner ear disease (except vestibular migraine(VM))
• • 4. Concurrent manifestation of psychiatric or psychological disorders.